Takeda Pharmaceutical Company Ltd
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori
Phase 3
Completed
- Conditions
- H. Pylori Infection
- Interventions
- First Posted Date
- 2012-01-06
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- Takeda
- Target Recruit Count
- 650
- Registration Number
- NCT01505127
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Takeda
- Target Recruit Count
- 150
- Registration Number
- NCT01500135
- Locations
- 🇺🇸
Nycomed Investigational Site, Bellevue, Washington, United States
Magnesium Pantoprazole 20mg b.i.d. vs Magnesium Pantoprazole 40mg q.d. on Intragastric Acid Inhibition
Phase 3
Withdrawn
- Conditions
- Gastric pH Control
- Interventions
- Drug: Magnesium Pantoprazole 20 mgDrug: Magnesium Pantoprazole 40 mgDrug: Placebo
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- Takeda
- Registration Number
- NCT01499693
- Locations
- 🇲🇽
Hospital Español de Mexico, Mexico City, Mexico
A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: INFS (Intranasal Fentanyl Spray)
- First Posted Date
- 2011-12-22
- Last Posted Date
- 2012-10-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 20
- Registration Number
- NCT01497288
- Locations
- 🇩🇪
Nycomed Investigational Site, Mannheim, Germany
TAK-875 Glimepiride Drug-Interaction Study
- First Posted Date
- 2011-12-21
- Last Posted Date
- 2012-09-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 28
- Registration Number
- NCT01496443
Effect of Febuxostat on Blood Pressure
- First Posted Date
- 2011-12-21
- Last Posted Date
- 2015-08-31
- Lead Sponsor
- Takeda
- Target Recruit Count
- 121
- Registration Number
- NCT01496469
Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
- First Posted Date
- 2011-12-21
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Takeda
- Target Recruit Count
- 105
- Registration Number
- NCT01496430
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
- First Posted Date
- 2011-11-29
- Last Posted Date
- 2016-06-01
- Lead Sponsor
- Takeda
- Target Recruit Count
- 2454
- Registration Number
- NCT01481116
Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
- First Posted Date
- 2011-11-24
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- Takeda
- Target Recruit Count
- 184
- Registration Number
- NCT01478971
- Locations
- 🇺🇸
Research Facility, San Antonio, Texas, United States
Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux Disease
Phase 3
Completed
- Conditions
- Non-erosive Gastroesophageal Reflux Disease
- Interventions
- Drug: TAK-438Drug: Placebo
- First Posted Date
- 2011-11-18
- Last Posted Date
- 2013-07-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 827
- Registration Number
- NCT01474369
© Copyright 2025. All Rights Reserved by MedPath